• EORTC abstracts at ESMO 2022
    Categories:

    Important new data from EORTC trials to be presented at ESMO 2022

  • EORTC Item Library provides considerable coverage of CTCAE side effects

    EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds

  • EORTC Patient recruitment Metastatic Melanoma
    Categories: ,

    EORTC Completes Patient Recruitment to Study of Treatment for unresectable or metastatic melanoma

  • Dr Martin Charles Mihm
    Categories: ,

    In Memoriam: Dr Martin Charles Mihm

  • E²-RADIatE - Illustration

    The 1500th patient has been enrolled in the E²-RADIatE cohort OLIGOCARE (RP-1822)

  • PRESS RELEASE: Better treatment for better heath: lifting the veil on treatment optimisation
    Categories: ,

    PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Categories:

    Long-term follow-up of chemoradiotherapy treatment in glioma patients shows significantly increased survival

  • Categories:

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older patients with acute myeloid leukemia